Forsta AP Fonden raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.7% during the second quarter, Holdings Channel reports. The firm owned 32,944 shares of the healthcare conglomerate’s stock after buying an additional 3,700 shares during the period. Forsta AP Fonden’s holdings in UnitedHealth Group were worth $6,108,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in UNH. Farmers & Merchants Investments Inc. increased its position in shares of UnitedHealth Group by 5.8% in the second quarter. Farmers & Merchants Investments Inc. now owns 65,256 shares of the healthcare conglomerate’s stock worth $12,100,000 after buying an additional 3,564 shares during the period. Rothschild Investment Corp IL acquired a new position in shares of UnitedHealth Group during the second quarter worth about $221,000. Osborn Williams & Donohoe LLC increased its position in shares of UnitedHealth Group by 3.1% in the second quarter. Osborn Williams & Donohoe LLC now owns 13,196 shares of the healthcare conglomerate’s stock worth $2,447,000 after buying an additional 400 shares during the period. Founders Capital Management LLC acquired a new position in shares of UnitedHealth Group during the second quarter worth about $205,000. Finally, Dubuque Bank & Trust Co. increased its position in shares of UnitedHealth Group by 50.7% in the second quarter. Dubuque Bank & Trust Co. now owns 1,939 shares of the healthcare conglomerate’s stock worth $360,000 after buying an additional 652 shares during the period. 86.21% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Incorporated (NYSE UNH) traded up 0.19% on Monday, reaching $193.39. The company’s stock had a trading volume of 1,033,687 shares. The firm has a market capitalization of $186.98 billion, a P/E ratio of 23.23 and a beta of 0.64. The firm has a 50-day moving average price of $189.36 and a 200 day moving average price of $174.75. UnitedHealth Group Incorporated has a 52-week low of $132.39 and a 52-week high of $196.04.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The business had revenue of $50.05 billion during the quarter, compared to analyst estimates of $49.97 billion. During the same quarter in the previous year, the firm posted $1.96 EPS. The business’s revenue for the quarter was up 7.7% compared to the same quarter last year. Equities analysts anticipate that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “UnitedHealth Group Incorporated (UNH) Shares Bought by Forsta AP Fonden” was reported by Watch List News and is the sole property of of Watch List News. If you are accessing this piece on another website, it was stolen and reposted in violation of U.S. and international copyright and trademark legislation. The original version of this piece can be viewed at https://www.watchlistnews.com/unitedhealth-group-incorporated-unh-shares-bought-by-forsta-ap-fonden/1487326.html.

A number of equities analysts recently issued reports on the company. Cowen and Company reaffirmed an “outperform” rating and issued a $220.00 price target (up from $175.00) on shares of UnitedHealth Group in a report on Friday. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $215.00 price target for the company in a report on Tuesday, August 1st. Oppenheimer Holdings, Inc. reaffirmed an “outperform” rating and issued a $205.00 price target (up from $203.00) on shares of UnitedHealth Group in a report on Friday, July 21st. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $210.00 price target (up from $190.00) on shares of UnitedHealth Group in a report on Saturday, July 22nd. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $208.00 price target on shares of UnitedHealth Group in a report on Friday, July 21st. One research analyst has rated the stock with a hold rating and twenty-four have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $202.20.

In related news, Director Gail R. Wilensky sold 5,540 shares of the business’s stock in a transaction that occurred on Friday, June 2nd. The stock was sold at an average price of $178.74, for a total transaction of $990,219.60. Following the completion of the transaction, the director now owns 60,516 shares in the company, valued at approximately $10,816,629.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction that occurred on Wednesday, June 7th. The shares were sold at an average price of $182.64, for a total value of $913,200.00. Following the transaction, the director now owns 75,735 shares of the company’s stock, valued at approximately $13,832,240.40. The disclosure for this sale can be found here. Insiders have sold a total of 15,540 shares of company stock valued at $2,873,320 in the last 90 days. Insiders own 0.89% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.